The yellow fever vaccination using the live-attenuated YF17D vaccine is one of the most effective immunizations available. A single dose provides long-lasting protection against the disease.

The US Department of Health and Human Services recommends a YFV-17D booster every ten years for those traveling to areas affected by the Yellow Fever virus. The vaccine was developed in 1938 at ...

causes up to 200,000 cases of yellow fever every year, despite the widespread use of a highly effective vaccine. The vaccine consists of a live, attenuated form of the virus called YFV-17D ...

Researchers have uncovered a critical role for a new immune signaling pathway in controlling infection by the flavivirus Yellow Fever Virus ... strain of the virus, called YFV-17D, which differs ...

TY014 neutralized nonmutated yellow fever virus and the YF17D strain in vitro and elicited 100% protection against the YF17D strain in a lethal mouse model, both as prophylaxis and as therapy.

It contains a live, weakened version of the virus that helps your body create immunity. The yellow fever 17D vaccine is among the most effective vaccines ever made. One shot lasts a lifetime.

Viscerotropic disease is a fulminant 17D virus infection of the liver and visceral organs resembling naturally acquired yellow fever. Neurotropic disease typically follows invasion of the brain by ...

Left panel: Loss of Type I IFN signaling leads to active replication of the attenuated YFV strain (YFV-17D), which is accompanied by viral invasion of the brain and damage to brain tissues ...

In the 20th century, a vaccine for yellow fever was developed to protect people in regions where the disease still flourishes. Epidemics continued, however, during every decade of the century, and ...